Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Head & Neck 1Gastrointestinal 1

Conditions

Stomach Neoplasms 1Sarcoma, Kaposi 1Nasopharyngeal Neoplasms 1Lymphoma, Primary Effusion 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1

Interventions

Oxaliplatin 290Capecitabine 206Fluorouracil 181Cisplatin 168Docetaxel 138S 1 (combination) 132Paclitaxel 121Leucovorin 116Irinotecan 106pembrolizumab 103Trastuzumab 71apatinib 56Nivolumab 56sintilimab 45Drug Therapy 43Surgical Procedures, Operative 37Radiotherapy 37Bevacizumab 37Ramucirumab 34titanium silicide 31Hyperthermic Intraperitoneal Chemotherapy 30Epirubicin 30Carboplatin 30tislelizumab 28Cyclophosphamide 27XELOX 24Tegafur 23Folfox protocol 22Albumin-Bound Paclitaxel 22camrelizumab 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Stomach Neoplasms × fialuridine × Clear all
NCT00982449 2018-09-17

124I-FIAU Imaging in EBV and KSHV Associated Cancers

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Completed
12 enrolled
GastrointestinalHead & NeckLymphoidSarcoma

Hodgkin Disease, Lymphoma, Non-Hodgkin, Nasopharyngeal Neoplasms, Sarcoma, Kaposi, Stomach Neoplasms, Lymphoma, Primary Effusion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡